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INTRODUCTION 
         Glaucoma is one of the leading causes of irreversible blindness 
throughout the world and its clinical evaluation, early diagnosis and 
treatment remains a challenge to the ophthalmologist even today. World 
Health Organisation statistics indicate that glaucoma accounts for 
blindness in 5.1 million persons or 13.5% of global blindness.1 
       Traditionally glaucoma has been classified as primary and secondary 
forms. Within this large group of glaucoma, the most common form is 
primary open angle glaucoma, characterized by intraocular pressure > 
21mm of Hg in atleast one eye, open and normal appearing anterior 
chamber angle and typical glaucomatous visual field loss or optic nerve 
head damage.2 
         At the other end of the spectrum, with regard to susceptibility to 
IOP are those patients with open, normal appearing anterior chamber 
angles, who have glaucomatous optic nerve head and visual field damage 
despite intraocular pressure< 21 mm of Hg on all occasions. They also 
have progressive glaucomatous damage with the absence of secondary 
causes for disc damage. 
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         These patients are said to have normal tension glaucoma/ low 
tension glaucoma. Some investigators feel that normal tension glaucoma 
is a variant of Chronic open angle glaucoma. Normal tension glaucoma is 
defined as typical Glaucomatous optic disc cupping and visual field loss 
in eyes with normal IOP, open angles and absence of any contributing 
ocular specific systemic disorders. Normal Tension Glaucoma accounts 
for 30% of  all glaucomas.1 
HISTORICAL REVIEW 
           In Hippocratic writings the term “glaucosis” refers to bluish-green 
hue of the affected eye. This term included a larger group of blinding 
disorders like cataract .  It was not until the nineteenth century that 
glaucoma was recognized as a distinct group of ocular disorders.  
           Von Graefe in the year 1857 first recognized optic nerve head 
abnormality with disturbance of vision & digitally normal tension. 
          In 1976, J. LAWTON SMITH suggested the theory of 
glaucomatous disc changes and field changes in an eye with a tension of 
21 mm Hg. He had also formulated the possible etiologies for normal 
tension glaucoma.1 
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ANATOMY OF ANGLE OF ANTERIOR CHAMBER 
              The angle is bounded at anterior side by the peripheral part of 
cornea, the trabecular meshwork, the anterior face of the ciliary body and 
posterior wall is formed by the iris. The sclera groove lies between the 
scleral spur posteriorly and anterior border ring of Schwalbe’s line 
anteriorly which is occupied by the canal of Schlemm and trabecular 
meshwork. 
TRABECULAR MESHWORK 
           It is a triangular structure the apex of which blends with the 
termination of descemet’s membrane and deep corneal lamellae. The base 
of the triangle is attached to the anterior surface of sclera spur, anterior 
surface of ciliary body and root of the iris. The sclera sulcus is converted 
into a circular channel called schlemm’s canal by the trabecular 
meshwork. 
         Histologically it is composed of lamellae made up a central core 
consisting of ground substance collagenous and elastic like fibres, 
surrounded by a single layer endothelial lining that is supported by a 
basement membrane. The anterior part of meshwork is non-filtering and 
posterior filtering part is divided into 3 portions. 
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1. UVEAL MESHWORK : 
 This portion adjacent to the anterior chamber are arranged in bands 
that extend form the iris root and ciliary body and extend to the peripheral 
cornea. It contains irregular openings ranging in size from 25-75 microns. 
2. CORNEO-SCLERAL MESHWORK 
 This portion extends from the sclera spur to the lateral wall of 
sclera sulcus. The openings varying from 5- 50 microns become 
progressively smaller as the schlemm’s canal is approached. 
3. JUXTA-CANALICULAR TISSUE 
 It is a thin layer of tissue 2-20 microns thick, the outermost portion 
of the meshwork adjacent to the Schlemm’s canal. 
AQUEOUS VEINS 
         They are exit channels of aqueous first described by Ascher.  They 
vary in size from 0.01-0.1 mm and interconnect Schlemm’s canal and 
episcleral veins.1,4 
ANATOMY OF THE OPTIC NERVE HEAD: 
Optic nerve head is defined as the distal portion of the optic nerve 
that  is directly susceptible to Intra- ocular pressure.Optic nerve head is 
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composed of the nerve fibers which originate in the ganglion cell layer of 
the retina and converge upon the nerve head from all points in the fundus. 
At the surface of the nerve head, these axons bend acutely  to leave the 
globe through a fenestrated sclera canal called the lamina cribrosa. Intra 
ocular portion of the optic nerve head has a diameter which varies from 
1.18mm to 1.75 mm with average of 1.5mm. 
DIVISIONS OF THE OPTIC NERVE HEAD 
1. SURFACE NERVE FIBRE LAYER: The innermost portion 
of the optic nerve head, composed predominantly of neurons. 
2. PRELAMINAR REGION: This layer begins at the posterior 
limit of the superficial nerve fibre layer and ends where the neurons pass 
through the lamina cribrosa. Predominant structures at this level are 
neurons and astrocytes. 
3. LAMINA CRIBROSA REGION: This portion contains 
fenestrated sheets of scleral connective tissue and occasional elastic 
fibres. Fascicles of neurons leave the eye through these openings. 
4. RETROLAMINAR REGION:  This is the part of the optic 
nerve head posterior to the laminar region. This area is charecterised by a 
decrease in astrocytes and the acquisition of myelin that is supplied by the 
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oligodendrocytes. The posterior extent of the retro lamina region is not 
clearly defined.1,3 
BLOOD SUPPLY OF THE OPTIC NERVE HEAD: 
ARTERIAL SUPPLY  
1. SURFACE NERVE FIBRE LAYER is mainly supplied by the 
arteriolar branches of the central retinal artery, which anastomose 
with vessels of Pre-laminar region and are continuous with the 
peripapillary retinal and long radial peripapillary capillaries. 
2. PRELAMINAR and LAMINAR are supplied primarily by short 
posterior ciliary arteries which form a perineural circular arterial 
anatomosis at the sclera level called circle of Zinn –Haller. The 
branches from this circle penetrate the optic nerve to supply the 
pre-laminar and the laminar regions along with the peripapillary 
choroid. 
3. RETRO-LAMINAR REGION is supplied by both the ciliary and 
retinal circulation with the former coming from recurrent pial 
vessels. 
 Peripheral centripetal vascular system formed by pial branches of 
the peripapillary choroid , arteries or Zinn , central retinal artery and 
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ophthalmic artery. Axial centrifugal vascular system formed by branches, 
from the intraneural part of the central retinal artery. 
VENOUS DRAINAGE 
The venous drainage of the optic nerve head is mainly by the 
central retinal vein. The pre-laminar region is also drained by the 
choroidal veins.1,4 
AXONS IN OPTIC NERVE HEAD: 
The arcuate fibers occupy the superior and inferior temporal 
portions of the optic nerve head, with axons from the peripheral retina 
taking a more peripheral location. The arcuate fibers are more susceptible 
to early glaucomatous damage. The papillomacular fibers spread over 
approximately one third of the distal optic nerve, primarily inferior 
temporally where the axonal density is higher. They intermingle with 
extramacular fibers, which may explain the retention of central vision 
during early glaucomatous optic atrophy.1,4 
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INTRAOCULAR PRESSURE 
Normal intraocular pressure may be defined as that pressure that 
doesnot lead to glaucomatous damage of the optic nerve head. 
Unfortunately, such a definition cannot be expressed in precise numerical 
terms, in that all eyes do not respond the same to given pressure levels.  
Three factors determine IOP : 
- Rate of aqueous humor production 
- Resistance to aqueous outflow across trabecular meshwork to 
schlemm’s canal 
- Level of episcleral venous pressure 
FACTORS EXERTING LONG-TERM INFLUENCE ON IOP 
1. GENETICS: The IOP within the general population appears to be 
under hereditary influence, through a polygenic, multifactorial mode 
of inheritance. 
2. AGE: There is an increase in IOP with age. 
3. GENDER: IOP is equal between the sexes in the agegroup of  20-40 
years. In older age groups, the apparent increase in mean IOP with age 
is greater in women. 
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4. REFRACTIVE ERROR: A positive correlation exixts between IOP 
and both axial length of the globe and increasing degrees of myopia. 
5. ETHNICITY: Blacks have higher IOP than whites. 
FACTORS EXERTING SHORT-TERM INFLUENCE ON IOP 
1. DIURNAL VARIATION: The intraocular pressure is subject to cyclic 
fluctuations throughout the day. The reported mean amplitude of daily 
fluctuation ranges from approximately 3mm Hg to 6 mm Hg. An 
amplitude greater than 10 mm Hg is generally considered pathologic. 
Many people reach their peak pressures in the morning hours, but 
others do so in the afternoon, in the evening or during sleep. The 
primary clinical value of measuring diurnal IOP variation is to avoid 
the risk of missing a pressure elevation with single readings. The 
intraocular pressures are recorded 6 times during the day at 4 hourly 
intervals and the graph is plotted connecting all points. No peak 
exceeding 21 mm of Hg confirms the diagnosis of normal tension 
glaucoma.5 
2. POSTURAL VARIATION: The IOP increases from sitting to the 
supine position with reported average differences of 0.3-6 mm of Hg. 
3. EXERTIONAL INFLUENCE: Prolonged exercise such as running 
lowers the IOP. Valsalva maneuver increases the IOP. 
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4. LID MOVEMENT: Blinking has been shown to raise the IOP. 
5. INTRAOCULAR DISEASES: Anterior uveitis and retinal detachment 
are associated with a reduced IOP. 
6. SYSTEMIC CONDITIONS: Systemic hypertension and hyperthermia 
are associated with elevated IOP. The IOP has been reported to be 
lower with hyperthyroidism and higher with hypothyroidism. Diabetic 
patients have been reported to have higher IOP than the general 
population. 
7. ENVIRONMENTAL CONDITIONS: Cold air reduces the IOP. 
8. GENERAL ANAESTHESIA: It is usually associated with reduction 
in IOP. Drugs like ketamine and succinyl choline cause a transient 
raise in IOP. 
9. OTHERS:  Alcohol and Heroin decrease the intraocular pressure 
whereas LSD  and corticosteroids increase the intraocular pressure.1 
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PATHOGENESIS OF GLAUCOMATOUS OPTIC ATROPHY 
The pathogenesis of glaucomatous optic atrophy has remained the 
matter of controversy since mid 19th century. 
The mechanical theory was proposed by Muller in which the 
elevated IOP led to direct compression and death of the neurons. 
The vasogenic theory was proposed by Von-Jaeger. According to 
this theory the structural and functional defects occurring in glaucoma are 
due to ischemia. The most elaborate support for this theory was advanced 
by HAYREH. He proposed that both an increase of IOP and fall of blood 
pressure lead to fall of perfusion in the ocular vessels. The fall of 
perfusion pressure can obliterate vessels first in the post laminar and  
retrolaminar region. The blood flow in the pre-laminar and post-laminar 
region and the choroid lack the ability of  autoregulation. Optic cupping 
results from chronic ischemia of the optic nerve head. 
There are two weak points in the above theory. According to 
HAYREH the primary site of axon damage is the prelaminar disc area, 
but it has been found that it is actually in the lamina cribrosa region. 
There is evidence in favour of effective autoregulation of blood flow in 
the optic nerve head. Thus, Glaucomatous damage to the optic nerve is 
multifactorial and is affected by more than just IOP elevation.1 
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CHARACTERISTICS OF GLAUCOMATOUS OPTIC ATROPHY  
1. FOCAL ATROPHY 
Selective loss of neural rim occurs primarily in the inferotemporal 
region of the optic nerve head. The temporal rim is typically involved 
after the vertical poles, with the nasal quadrant being the last to be 
involved. The focal atrophy of the neural rim often begins as a small 
discrete defect usually in the inferotemporal quadrant which has been 
called as polar notching. 
2. CONCENTRIC ATROPHY 
Glaucomatous  damage less commonly results in concentric 
enlargement of the cup more often directed inferotemporally or 
superotemporally. Loss of neural rim usually begins temporally and then 
progresses circumferentially towards the poles . this is called as temporal 
unfolding. 
3. DEEPENING OF THE CUP  
Exposure of the underlying lamina cribrosa by the deepening of the 
cup is recognized by the gray fenestra of the lamina which is called as the 
laminar dot sign. 
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4. ADVANCED GLAUCOMATOUS CUPPING  
If the progressive changes of glaucomatous optic atrophy are not 
arrested by appropriate measures to reduce IOP , the ultimate result is 
total cupping which is seen clinically as a white disc with  loss of neural 
rim tissue and bending of all vessels at the margin of the disc. This has 
also been called as bean pot cupping, because the cross section of a 
histological specimen reveals extreme posterior displacement of the 
lamina cribrosa and undermining of the disc margin.1,2,5,21 
VASCULAR SIGNS OF GLAUCOMATOS OPTIC ATROPHY 
a. SPLINTER HEMORRHAGES : These are present near the margin 
of the optic nerve head and are a common feature of glaucomatous 
damage. They occur more commonly in patients with normal 
tension glaucoma. They tend to come and go so that they may be 
seen in one visit and be gone in the next only to reappear at a later 
date in the same or a new location. The most common location is 
the inferior quadrant, most often seen in the early to middle stages 
of glaucomatous damage. A thin neuroretinal rim was found to be a 
risk factor for the development of optic disc hemorrhages. They 
commonly occur with minimal pressure elevation or in eyes with 
normal-tension glaucoma.24 They also occur more commonly on 
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diabetic patients with glaucoma. It should be viewed as a sign that 
the glaucoma may be out of control.1 
b. BARING OF THE CIRCUMLINEAR VESSEL 
In many normal optic nerve heads , one or two vessels may curve 
to outline a portion of the physiological cup. With glaucomatous 
enlargement of the cup, these circumlinear vessels may be bared from the 
margin of the cup. 
c. NASALISATION OF VESSELS 
Nasal displacement of the retinal vessels on the optic nerve head is 
a sign of glaucomatous cupping. 
d. BAYONETING OF THE VESSELS 
If a retinal vessel crosses the sharpened rim , it will bend at the 
edge of the disc creating the bayoneting sign.1,2 
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VISUAL FIELD LOSS IN GLAUCOMA 
1. PERIPHERAL LOSS 
Defects along the peripheral boundaries of the visual field eg; 
peripheral nasal steps, vertical steps and temporal sectoral defects are 
most often found in association with early glaucomatous visual field loss. 
2. LOCALIZED NERVE FIBER LAYER DEFECTS: 
The glaucomatous process causes initial damage to one or more 
axon bundles creating a localized visual field defect. 
3. ARCUATE DEFECTS 
An arcuate visual defect is strongly suggestive of glaucoma. This 
arcuate scotoma starts from the blindspot and arches above and below 
fixation or both to the horizontal median raphe, corresponding to the 
arcuate retinal nerve fibers. 
As the field defects develop within the arcuate area they most often 
appear as paracentral scotomas. Occasionally the early arcuate defect may 
connect with the blind spot and taper to a point in a slightly curved course 
which has been called as Seidel scotoma.  As the isolated defects enlarge 
and coalesce, they form an arching scotoma that eventually fills the entire 
arcuate area from the blind spot to the median raphe , which is called as 
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Bjerrum scotoma. With further progression , a double arcuate or ring 
scotoma develops. 
4. NASAL STEP 
Unequal contraction on the peripheral side of the defect due to loss 
of corresponding bundles of peripheral fibers produces the peripheral 
nasal step of Ronne.1,2,5,11 
5. EARLY GLAUCOMATOUS FIELD DEFECTS 
a. CONCENTRIC CONTRACTION 
Isopter contraction is more often marked in the nasal field called   
as crowding of nasal isopters is a early field defect in glaucoma.  
b. ANGIOSCOTOMATA 
These are long branching scotomas above and below the blindspot    
which are presumed to result from shadows created by the large retinal 
vessels .1 
6. ADVANCED GLAUCOMATOUS FIELD DEFECTS  
The natural history of progressive glaucomatous field loss is 
eventual development of a complete double arcuate scotoma, which 
coalesce nasally at the horizontal raphe and may extend to the peripheral 
limits in all areas except the temporal side . This results in a central island 
and a temporal island in advanced glaucoma.1,2 
 
17
CLASSIFICATION OF  GLAUCOMAS 
 
The major classification of the glaucomas relates to the 
configuration of the anterior chamber angle and the age of onset of the 
disease. Glaucomas are classified into: 
1. Open angle glaucoma- 
a. Primary open angle glaucoma 
b. Normal tension glaucoma 
c. Juvenile glaucoma 
d. Glaucoma suspect 
e. Secondary open angle glaucoma 
2. Angle closure glaucoma- 
a. Primary angle closure glaucoma 
b. Secondary angle closure glaucoma either with or without 
pupillary block 
3. Childhood glaucoma- 
a. Primary congenital or infantile glaucoma 
b. Glaucoma associated with congenital anomalies 
c. Secondary glaucoma in infants and children.1 
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NORMAL TENSION GLAUCOMA 
 Normal tension glaucoma is defined as a condition in which 
cupping of the optic nerve head , loss of the neuroretinal rim and visual 
field defects similar to other forms of chronic glaucoma in which IOP 
level outside the statistically normal range without treatment has not been 
documented nor is any other cause for these changes apparent.1   
 Normal tension glaucoma(NTG) also called low tension glaucoma, 
is a diagnostic and therapeutic conundrum.  NTG is classified into 
progressive and non-progressive forms.1,28 
 Non- progressive NTG is usually due to transient hemodynamic 
catastrophe and is actually a form of pseudo NTG. Progressive NTG may 
worsen more rapidly than primary open- angle glaucoma despite medical 
and surgical treatment.1 
 Both the eyes are affected in approximately 70% of the patients, 
and the disease is more commonly seen in patients over the age of 60.39,40 
Women are affected about twice as often as men and NTG represents 10-
30 % of all forms of glaucoma.1,38 
 Open angle glaucoma is a spectrum of disorders in which elevated 
IOP is the most influential and glaucomatous optic atrophy predominate 
at the other end. Controversy remains about whether NTG represents a 
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distinct disease entity or is simply POAG with IOP within the average 
range. 
            In normal tension glaucoma risk factors other than IOP may play 
an important role. Many authorities have hypothesized that local vascular 
factors may have a significant role in the development of this disorder. 
 
Normal tension glaucoma is divided into two  groups: 
1. Senile sclerotic group: 
This constitutes old patients with vascular disease and is 
characterized by shallow sloping of neuroretinal rim. 
2. Focal ischemic group: 
This constitutes relatively younger patients with deep, focal polar 
notching of the neuroretinal rim.1 
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DIFFERENCE BETWEEN NTG AND COAG 
Clinical differences between NTG and COAG are as follows, 
1. The neural rim has been found to be significantly thinner in NTG  
than in COAG, especially inferiorly and inferotemporally.19 
2. Cupping in NTG is found to be more broadly sloping than in 
COAG. 
3. Optic disc hemorrhages are more prevalent in NTG. 
4. Localized retinal nerve fiber layer defects are found in NTG as 
compared to diffuse nerve fiber layer defects in COAG. 
5. Patients with NTG have larger peripapillary atrophy particularly in 
zone beta than in COAG. 
6. NTG patients have deeper and more localized scotomas .23 
7. Higher incidence of proximity of scotomas to fixation in NTG.1 
Although NTG is distinguished from COAG by an IOP that is 
never recorded to exceed 21mm Hg , the pressures do tend to be higher 
than those in the normal population. An IOP reduction of atleast 30% is 
significantly associated with protection of visual field and nerve status .  
Hayreh suggested that NTG differs from anterior ischemic optic 
neuropathy only in that the latter is a more acute process.1 
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ASSOCIATED RISK FACTORS 
 
NTG can be mimicked by many conditions. Elevated IOP can be 
obscured in patients with systemic medical beta blockers. NTG patients 
have significantly greater nocturnal blood pressure drops than normal 
patients. In  normal tension glaucoma, there are two aspects to the 
relationship between systemic blood pressure and optic nerve damage. 
One is whether patients with normal tension glaucoma have chronic 
blood pressure abnormalities. The other is the possible role of episodes of 
acute hypotension in patients with normal tension glaucoma.1,21  
A greater lack of autoregulation of optic nerve head circulation  is 
noted in NTG. Patients with NTG have an increased frequency of 
headaches with or without migraine. An abnormally reduced blood flow 
in the fingers in response to exposure to cold  have been found.1   
Hematologic abnormalities like increased blood and plasma 
viscosity and hypercoagulability. Hypercholesterolemia  has also been 
reported to be higher among patients with NTG. An increased incidence 
of paraproteinemia and autoantibodies including antirhodopsin antibodies 
and anti- glutathione S tranferase are present in NTG.1,21 
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CLINICAL PRESENTATION 
Patients may complain of reduced vision or other visual difficulties 
resulting from extensive visual field loss. More often the abnormal 
appearance of the optic nerve head is noted during examination of an 
asymptomatic patient. Because these patients have normal IOP and good 
central vision the disease is often missed when proper evaluation of the 
optic nerve head is not done. Routine use of slit lamp with Hruby lens or 
handheld 78 D or 90 D lens increases the likelihood of detecting cupping. 
EVALUATION OF NORMAL TENSION GLAUCOMA 
Before making a diagnosis of NTG, clinician should measure the 
patient’s intraocular pressure at various times during the day. Since the 
mathematical calculation for Goldmann  Applanation tonometer is  based 
on a presumed average central corneal thickness(CCT) , variations in this 
parameter can lead to errors in the measurement. Variations of CCT in 
normal corneas can lead to falsely high IOP with thicker corneas and 
falsely low IOP recordings in thinner corneas.1  
Gonioscopy to be performed to rule out angle closure, angle 
recession and previous signs of inflammation. Careful stereoscopic disc 
evaluation is essential to rule out other congenital or acquired disc 
anomalies, such as optic nerve coloboma, drusen or enlarged cup. 
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Clinician must also consider the patient’s medical history, any record of 
cardiovascular disease and low blood pressure caused by hemorrhage, 
myocardial infarction or shock. If diagnosis couldnot be established or if 
findings are atypical, neurological evaluation to be done. 
DIFFERENTIAL DIAGNOSIS 
  The differential diagnosis of normal tension glaucoma includes, 
1. Congenital disorders: Optic nerve pit or coloboma, Autosomal 
dominant optic atrophy.18,22 
2. Acquired disorders : 
‐ Past history of steroid use by any route which may have led to 
elevated IOP 
‐ Past history of trauma or surgery that may have led to elevated IOP 
‐ Hemodynamic crisis 
‐ Methyl alcohol poisoning 
‐ Optic neuritis 
‐ Anterior Ischemic optic neuropathy 
‐ Non arteritic ischemic optic neuropathy 
‐ Compressive lesions of the optic nerve and tract 
‐ Trauma 
‐ Wide diurnal fluctuation in IOP1,33 
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MANAGEMENT 
Although damage to the optic nerve head and visual field may 
progress even at low normal pressures in normal tension glaucoma, there 
is compelling evidence for further IOP reduction in this disorder.  An 
additional aspect in the management of  Normotensive glaucoma is the 
treatment of cardiovascular abnormalities like anemia, congestive heart 
failure, transient ischemic attacks and cardiac arrhythmias to ensure 
maximum perfusion of the optic nerve head. 
          Therapy for NTG can be difficult and controversial. The goal of 
therapy should be to achieve an IOP as low as possible without inducing 
complications. 
         Systemic medications such as calcium channel blockers are 
advocated because of the possible beneficial effects of increasing 
capillary perfusion of the optic nerve head. If systemic treatment with 
calcium channel blockers is undertaken, it should be co-ordinated with 
the patient’s primary care physician because of the possible side effects. 
        Medical therapy is the most common initial approach in treating 
NTG. As with all glaucomas, it is useful for the ophthalmologist to 
change or add medications to one eye at a time so that contralateral eye 
can be used as a control to assess therapeutic response. More than 25% of 
baseline pressure needs to be reduced to assess the progression.  
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        The Beta blockers were also tried in normal tension glaucoma. 
Timolol was found to have no change in reduction of ocular perfusion at 
night. Levobunol and Betaxolol decrease the intraocular tension and also 
have a unique property of increasing the pulsatile ocular blood flow to the 
optic nerve. 
           Latanoprost causes IOP reduction through out the night by 
increasing the uveoscleral out flow . 20-30% IOP reduction is attained 
and it causes7.9% increase in perfusion pressure of the optic nerve head. 
Bimatoprost increases the optic nerve head perfusion.Travoprost is 
similar and comparable to latanoprost. 
          Brimonidine  is an Alpha –2 adrenergic  receptor agonist  and has 
been proposed to help in NTG by its newer mode of action ( decreased 
aqueous production &  increased trabecular outflow ). Secondly it a 
neuroprotective it protects the retinal ganglion cells. 
        Calcium channel Blockers  block membrane bound calcium channels 
& inhibit calcium influx causing relaxation of smooth muscle cells in 
vascular walls , a decrease in vascular tone & improvement in blood flow. 
Flunarizine improves blood flow in NTG.  Nimodepine & Nilvadepine 
show beneficial effects in NTG patients. It is still under research process. 
       Other Neuro supportive drugs such as Methycobalamine has been 
widely used now and proved to be effective. Their exact mechanism of 
action is not known. 
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       If medications are ineffective in controlling the disease, laser 
trabeculoplasty can be tried. Glaucoma filtering surgery may be indicated 
in an attempt to obtain the lowest IOP. It carries risk of postoperative 
hypotony. Hence the option is preserved for those patients with 
undoubted field progression .Surgery should not be performed on making 
the diagnosis. 
        When surgical management is indicated, trabeculectomy with 
mitomycin c is preferred. Antifibrotic agents may be used to improve the 
success rate of filtering surgery and to reduce the postoperative and long 
term IOP in these patients with low target IOPs. The goal of treatment in 
normotensive glaucoma is to achieve a targeted pressure reduction of 
around 30% from the initially detected intraocular pressure.1 
Collaborative  Normal Tension Glaucoma Trial (CNTGS): 
         The aim of the study was to determine if  IOP lowering treatment is  
effective in reducing the progression of NTG. 140 patients randomized to 
receive either medication /surgery ( End point was reduction of IOP by 
30%) or to have no treatment. The untreated eyes had 35% chance of 
progression compared to 12% chance of progression in the treated group. 
Collaborative normal tension glaucoma study concluded that IOP 
reduction in normal tension glaucoma decreases glaucoma progression.1 
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ASSESSMENT OF FIELDS BY AUTOMATED PERIMETRY 
Automated perimetry is accepted as the standard way of measuring 
the visual field. The standard protocol of static white on white stimuli is 
called as standard automated perimetry. A major limitation of tangent 
screen and arc erimeters was a lack of standardization of the test objects 
and the background as well as the patient’s fixation. 
The computers have provided the new capability that was not 
possible with the manual perimetry, including random presentation of 
targets, estimation of patient’s reliability, reduced variability and 
statistical evaluation of data at many levels. The introduction of threshold 
strategies makes it more accurate, reliable and faster than manual 
perimetry. 
Static targets are most commonly used in automated perimetry. The 
targets may either be projected into the bowl which is the current 
standard, or illuminated from light emitting diodes or fiberoptics. The 
standard stimulus in most automated perimeters is a white light on a 
white background which tests the patient’s differential light sense. 
         With each Octopus model the stimuli are projected onto the bowl 
and fixation is  monitored by both the corneal light reflex method and a 
television view of the patient’s eye. 
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TEST PATTERNS 
The central 24-30 degrees field with 6 degree separation between 
test locations is the commonly used test pattern. The 6 degree grid may 
miss the physiologic blind spot as well as some glaucomatous field 
defects and hence tighter grids are suggested for meticulous testing of 
fields. Static testing of the peripheral nasal fields provides a valuable 
information in detecting glaucomatous defects. 
TESTING STRATEGIES 
All fully automated perimetries take the advantage of the 
computers by using random presentation of the targets to avoid patient 
anticipation of the next presentation sites. An additional technique called 
as adaptive technique is used, in which stimuli are presented according to 
the presumed normal threshold contour based on age corrected normal 
data and patient’s response to preliminary spot tests. Fully automated 
perimeters provide suprathreshold and full threshold measurements. 
FULL THRESHOLD PERIMETRY 
Threshold static perimeters are capable of a variety of testing 
strategies. The most commonly used programs measure the retinal 
threshold at 70-80 points within the central 24-30 degrees . a 
suprathreshold target is first presented and then it’s luminosity is 
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gradually increased or decreased until the patient’s threshold is crossed . 
the threshold is then crossed a second time with smaller increments of 
change in luminosity to refine the threshold determination.  
TENDENCY ORIENTED PERIMETRY 
It is another fast strategy algorithm available on new Octopus 
perimeters. It also uses a computational approach to estimate threshold 
values by extrapolating information from surrounding test points. The 
mean testing time for the TOP strategy was slightly more than 2 ½ 
minutes, compared to approximately 4 minutes for SITA fast. 
FASTPAC 
Another threshold testing strategy to reduce testing time is the 
FASTPAC program of the Humphrey field analyzer , which estimates 
thresholding from a single threshold crossing in 3db increments, in 
contrast to standard double threshold crossing with 4db and 2 db. 
SWEDISH INTERACTIVE THRESHOLD ALGORITHM 
This algorithm significantly minimizes test time without significant 
reduction of data quality. Two versions of SITA are currently available: 
SITA standard and SITA fast. 
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INTERPRETATION OF RESULTS 
With most full threshold programs , a percentage of random 
locations are retested to determine the reproducibility at those points. The 
patient’s general reliability is assessed with a series of false-positives 
(patient responds when no target is presented) and false negatives (patient 
fails to respond to a stimulus of maximum intensity where a stimulus was 
previously reported to be seen), as well as the frequency of fixation losses 
and the number of stimuli required to complete the test. 
The Octopus also provides printouts with probability, corrected 
probability, comparison and corrected comparison. 
Global indices are the mathematically analyzed data allowing 
detection of more subtle visual field abnormalities. The average of all 
points in the comparison plot gives the mean defect. These indices 
primarily reflect diffuse changes. The way to detect localized defects is to 
calculate the number of threshold values that deviate significantly from 
the age corrected normal which is called as loss variance. Corrected loss 
variance takes into account the short term fluctuations.1 
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ROLE OF OPTICAL COHERENCE TOMOGRAPHY IN 
GLAUCOMA 
Optical Coherence Tomography (OCT) was pioneered by Fujimoto 
and others at Massachesetts eye institute. OCT was first applied in the 
eye by Puliafito in 1986. It was developed as a commercial product by 
Humphrey division of Carl Zeiss. 
OCT is a non invasive cross-sectional diagnostic imaging modality 
that is capable of producing highly accurate structural representations of 
the retinaand the posterior segment tissues. The resolution limit of OCT is 
8 micron. A highly reflective red layer at the vitreoretinal interface 
corresponds to the retinal nerve fiber layer.1,9 
The principle of OCT involves a low- coherence infrared diode 
laser source, which is divided into reference and sample paths. Reflected 
sample light from the subject’s eye creates an interference signal with the 
reference beam, which is detected in a fiberoptic interferometer. Cross- 
sectional images of the retina and disc are then constructed from a 
sequence of signals. 
The straight blue line which connects the edges of the RPE 
represents the disc diameter. Automated determination of the disc margin 
as the end of the RPE was used for this analysis. The cup diameter is 
 
32
denoted by a parallel red line constructed 150 micron anterior to disc 
diameter. The structures below the red line are defined as the cup. 
Structures above the red line, the neuroretinal rim. Three dimensional 
spectral domain (Fourier domain OCT) gives faster and more accurate 
results.17 
Optic nerve head analysis is performed with a fast optic nerve scan 
protocol. Six radially linear scans centered on the ONH were analysed 
cross-sectionally. The Retinal nerve fiber layer thickness(RNFL) 
measured be averaging the results of 3 sequential circular scans with 
diameter of 3.4 mm centered at ONH using fast RNFL scan mode. RNFL 
thickness is determined by the difference in distance between the 
vitreoretinal interface and a posterior boundary based on a predefined 
reflectivity signal level. RNFL thickness is determined at 256points 
covering a set diameter (3.4 mm) around the center of the optic disc 3 
times. 
The high axial resolution of OCT allows for direct measurement of 
RNFL thickness with micron scale accuracy. Radial scans through the 
disc provide contour information that is valuable in objectively assessing 
optic disc cupping and NRR thinning. 
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In OCT,  A scan was defined by a sequence of data points typically 
acquired in order of increasing depth. B and C scan images are defined as 
a matrix of pixels, typically acquired either by rows or columns. 
The line graph displays RNFL thickness on the vertical axis and A 
scan location on the horizontal axis. The display of the RNFL thickness 
along the scanned circle begins temporally at 0 degree. The RNFL 
thickness profile is then plotted in a clockwise direction for the right eye 
and counterclockwise direction for the left eye. In line graph presentation, 
the percentile value derived from the normative database are represented 
as colour bands. 
The pitfalls of this imaging are , the image quality is dependant on 
the operator skill, patient related factors like the pupil diameter and media 
clarity. 
However NFL thinning can often be detected before visual field 
loss or progression of cupping is identified. Clinically, cases of advanced 
glaucoma exhibit direct correlation between areas of NFL thinning and 
visual field defects. Objective assessment of glaucomatous change by 
OCT may clarify the subjective variability of visual field testing and 
biomicroscopic nerve head evaluation. 1,9 
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FUNDUS FLUORESCEIN ANGIOGRAPHIC STUDIES IN 
GLAUCOMA 
 
           Normal flourescein pattern of the optic nerve head is usually 
described in three phases. 
1. An initial filling or preretinal arterial phase- represents the filling 
of prelaminar and laminar regions by posterior ciliary arteries. 
2. The peak fluorescence or retinal arteriovenous phase – represents 
the filling of the dense capillary plexus on the nerve head. 
3. A late phase consists of delayed staining of the optic nerve head –
represents the flourescein in the connective tissue of the lamina 
cribrosa. 
The glaucomatous eyes reveal two types of filling defects. 
‐ Persisting hypoperfusion or absolute filling defects 
‐ Transient hypoperfusion or relative filling defects 
         Persisting hypoperfusion or absolute filling defects are more 
common in normal tension glaucoma. They are said to correlate with 
visual field defects. The filling defect may either be focal or diffuse. 
Focal defects occur in inferior or superior poles of optic nerve head. In 
glaucomatous eyes they are most seen in the wall of the cup. Focal 
defects are common in normal tension glaucoma.32  
 
35
 In addition, in normal tension glaucoma, the choroidal phases are 
delayed and retinal arterio-venous phase times are prolonged possibly 
from the increased resistance in the central retinal and posterior ciliary 
arteries.1,25,30 
TRANSCRANIAL DOPPLER ULTRASOUND OF OPHTHALMIC 
ARTERY 
 Transcranial Doppler ultrasound is used to study non-invasively 
the blood flow velocity of intracranial vessels including the ophthalmic 
artery flow velocity. It consists of a 2 MHz pulsed Doppler with a fast 
Fourier transformation which is used to derive and analyse the spectrum 
of returning echoes of various frequencies. The peak systolic velocity, 
mean envelope velocity, end diastolic velocity and the resistivity index 
are measured.28 
 The latest is the confocal scanning laser Doppler flowmetry. 
Normal tension glaucoma is characterized by reduced blood flow in the 
peripapillary retina, suggesting that blood flow deficits accompany and 
may contribute to the disease development in these patients.29 
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AIMS OF THE STUDY 
1. To analyse the clinical presentation, risk factors and intraocular 
pressure level in normal tension glaucoma.  
2. To detect the field defects by automated perimetry and to correlate 
them with the retinal nerve fiber layer thickness measured by OCT. 
3. To evaluate the response to treatment and follow up of the patients 
to detect progression or regression in the field defects. 
4. To find the fundus flourescein angiographic studies of the optic 
nerve head and retina in normal tension glaucoma. 
INCLUSION CRITERIA 
1. Patients without lens changes or minimal lens changes were taken. 
2. Patients with gonioscopically open angles  
3. Intraocular pressure < 21 mm of Hg (after Central corneal 
thickness correction). 
EXCLUSION CRITERIA 
1. Patients with dense lens changes.  
2. Intraocular pressure > 21 mm of Hg even on one instance during 
diurnal variation test. 
3. Presence of peripheral anterior synechia in gonioscopy. 
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MATERIALS AND METHODS 
The study was a prospective case series conducted at Glaucoma 
services at Regional Institute of Ophthalmology from the period between 
July 2007 – July 2009.  The study was done in 100 patients (198 eyes) of 
established Normal tension glaucoma after complete evaluation 
CLINICAL EXAMINATION 
The clinical assessment of the patient began with a thorough 
history taking about  defective vision, defective field of vision, frequent 
change of glasses were enquired. Any serious operation or accident with 
significant blood loss, cardiac arrest, myocardial infarction, migraine, 
diabetes, hypertension, hypotension, poor nutrition, Raynaud’s 
phenomenon, other connective tissue and autoimmune disorders, tobacco 
or alcohol use and neurological problem were enquired about. Family 
history of glaucoma , any prior head trauma or eye injury , prior cataract 
surgery, history of anti-glaucoma drug usage, history of steroid usage 
either systemically or topically were also enquired. 
Visual acuity was recorded and refraction was done in all cases to 
correct refractive errors. Ocular examination of  both eyes with slit lamp 
bio-microscope to detect any features of  secondary glaucoma and lens 
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changes were done. Gonioscopy was done and the angles were graded by 
using Shaffer’s grading method.  
Intra-ocular pressure was measured using Goldmann Applanation 
tonometer and the Central corneal thickness was measured by 
Pachymetry. The values of Goldmann tonometer readings were taken as 
such for central corneal thickness (CCT) values between 510 -530 
microns. For readings beyond that, correction factor of 3mm for every 50  
microns1, so that IOP + 3 mm of Hg for every 50 microns decrease in 
CCT( in thinner corneas) and – 3mm of Hg for every 50 microns increase 
in CCT (in thicker corneas) was taken. 
Diurnal variation test (phasing) was done in all patients by 
recording 6 readings  each 4 hours apart throughout the day and plotting 
the graph connecting all the 6 points such that none of the recordings 
were beyond 21 mm of Hg. The recording was done using Perkins 
applanation tonometer. 
Fundus examination was done using + 90 D slit lamp 
biomicroscopy and the cup: disc ratio was noted. Associated findings like  
Nasalisation,Bayonetting, Laminar dot sign, Baring of circumciliary 
vessels and Splinter hemorrhages near the disc were noted.   
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Field charting was done by computer assisted static Automated 
perimetry (Octopus 123 , G1 x program, TOP strategy) for both the eyes. 
Reliable field testing with false positives and false negatives below 30 
percent were taken for the study.  
Optical Coherence Tomography was done in all patients to record 
the retinal nerve fiber layer thickness  in all the four quadrants.  
All the patients were started on 0.15% Brimonidine eye drops 
(alpha 2 agonist) twice a day and oral neurovitamins once daily.  
The patients were followed up based on the fundoscopy and the 
extent of their field defects  after 3 months and 6 months. Intraocular 
pressure recording, fundoscopy, field testing by automated perimetry was 
done in every visit. The response of intraocular pressure to medical 
treatment was noted. Fundus changes were recorded. 
Any progression or regression or static nature of the field defect 
were noted. The patients were asked to either continue Brimonidine eye 
drops or substituted with Betaxolol or Latanoprost based on their 
response to therapy. The patients were reviewed after 3 months for repeat 
IOP and field testing. A decision whether to continue medical treatment 
or surgical treatment was then taken.    
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Blood pressure measurement, Hemoglobin and Lipid profile was 
done in all patients. Thorough cardiology and neurology evaluation was 
done for all the patients. 
15 cases of Normal tension Glaucoma were taken after informed  
consent for Fundus Fluorescein Angiography of the retina and the optic 
nerve head. Patients with renal failure or cardiac failure were excluded 
from the test.  The procedure was explained to the patient.The choroidal 
filling time, arterio-venous transit time and the filling defects on the optic 
nerve head were noted.    
  
 
41
OBSERVATION AND ANALYSIS 
 198  eyes of 100 patients with intraocular pressure < 21 mm of Hg 
were taken for the study. 2 patients were one eyed, 1 had leucomatous 
corneal opacity and the other patient had evisceration done in one eye.  
1. AGE DISTRIBUTION 
            The ages of patients studied varied from 21- 70 years. The 
average age incidence was 41-60 years. This is because most of this age 
group patients come for ophthalmic examination either for refractive 
error or defective vision due to lens changes. Thereby, normal tension 
glaucoma is detected by fundus examination and intraocular pressure 
measurement.     
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TEMPORAL RNFL THINNING 
        
 
 Out of the 92 eyes with temporal retinal nerve fiber layer thinning, 
12 eyes had superior arcuate area defects, 8 eyes had inferior arcuate area 
defects, 17 eyes had both arcuate and 14 eyes had paracentral defects. 25 
eyes had fixation area defects whereas 16 eyes had no field defects. 
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TREATMENT 
 
 The intraocular pressure was brought under control in 194 
eyes(97%) and was still static in 4 eyes(2%). The fundus changes were 
static in 196 eyes (98%) and were progressive in 2 eyes(1%). The field 
changes were static in 171 eyes(86%) on comparison with the previous 
fields and 23 eyes(11%) showed regression of field defects and 4 
eyes(2%) showed progression.  
 The treatment was changed to latanoprost in 2 eyes which showed 
progression. In the other 2 eyes,  Brimonidine + Timolol Combination 
eye drops twice a day was given for one month. The  intraocular pressure 
remained static, so surgery (trabeculectomy) was done to prevent further 
progression, since they had defective vision in the other eye. On post 
operative follow up the intraocular pressure was consistently at 8 mm of 
Hg and 10 mm of Hg in both the eyes respectively, thus bringing down 
the intraocular pressure by 30 % in both the eyes. 
188
4
4
2
0 20 40 60 80 100 120 140 160 180 200
BRIMONIDINE
LATANOPROST
BETAXOLOL
SURGERY
TREATMENT
 14
 
 
arm
de
ner
aut
AR
 
is 
In 
pat
NO. 
OF 
EYES
. FUND
RETIN
Fundu
-choroida
fects on th
ve head 
omated pe
M- CHO
The no
10-12 seco
our study
ients.  
 
US FLU
A AND 
s flouresc
l filling 
e optic nev
were corr
rimetry-(O
ROIDAL
rmal arm
nds and i
, the arm c
ORESC
OPTIC N
ein angiog
time, arte
e head we
elated wit
ctopus 30
 FILLING
 choroidal
n more tha
horoidal f
EIN AN
ERVE HE
raphy wa
riovenous
re noted.
h the fiel
1- G1x pr
 TIME 
 filling tim
n 50 year
illing tim
GIOGRA
AD 
s done in 
 transit ti
The filling
d defects 
ogram- TO
e in less t
s of age it
e was dela
PHY O
15 patien
me and t
 defects on
as record
P Strateg
han 50 ye
 is 12-15 
yed in 11
60
F THE
ts and the
he filling
 the optic
ed by the
y). 
 
ars of age
seconds.30
 out of 15
 
 
 
 
 
 
 
 
  
AR
 
 
 
ab
pat
no
pro
po
NO. 
OF 
EYES 
TERIO- 
The no
ove 15 sec
ients had
rmal tens
longed po
sterior cili
 
 
1
1
1
1
VENOUS
rmal arter
onds is c
 prolonge
ion glauco
ssibly from
ary arterie
0
2
4
6
8
0
2
4
6
0
 TRANSI
io-venous
onsidered 
d arterio-
ma , ret
 the incr
s. 
5
TIME 
T TIME
 transit ph
abnormal
venous tr
inal arteri
eased resis
10
IN SECONDS
ase time i
.30 In our 
ansit tim
o venous
tance in th
15
s 10-12 se
study, 10 
e. In pati
 passage 
e central r
20 2
61
 
conds and
out of 15
ents with
times are
etinal and
5
 
 
 
 
 
 FI
DI
 
hy
tow
Th
oc
he
ey
 
LLING 
STRIBUT
Sector 
pofluoresc
ards the c
is is usua
cur prima
ad.1,25 In o
es (11) had
13
DEFEC
ION 
shaped  
ence exte
enter of th
lly seen i
rily in the
ur study 
 both supe
TS ON
hypofluor
nding fro
e disc inv
n normal 
 inferior 
17 out of 
rior and in
4
 THEO
escence 
m the e
olving the
tension g
and super
30 eyes ha
ferior fill
2
11
PTIC 
refers to 
dge of th
 adjacent p
laucoma. 
ior poles 
d filling 
ing defects
NERVE 
a wedg
e neurore
art of the 
These foc
of the op
defects. M
. 
SUPERIOR
INFERIOR
BOTH SUPE
AND INFER
NO FILLING
DEFECTS
62
HEAD
 
e shaped
tinal rim
optic cup.
al defects
tic nerve
ost of the
RIOR 
IOR
 
 
 
 
 
 
 
 
 
63
 
CORRELATION OF FILLING DEFECTS ON ONH WITH THE 
FIELD DEFECTS 
NO. OF 
EYES 
AREA OF 
SCOTOMA 
FILLING 
DEFECTS 
2 /2 SUPERIOR 
ARCUATE 
INFERIOR 
3/4 INFERIOR 
ARCUATE 
SUPERIOR 
8/11 BOTH ARCUATE BOTH SUPERIOR 
AND INFERIOR 
 
 The filling defects on the optic nerve head were compared and 
correlated with the field defects. Most of the eyes (13 /17 eyes) had 
corresponding scotomas either in the superior arcuate area or inferior 
arcuate area or both. Since the areas of absolute filling defects indicate 
persisting hypoperfusion, they are said to correlate with visual field loss. 
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RESULTS 
• The commonest age group(68%)  in the study was between 41-
60 years. 
• Males (61%) were predominant than the females (39%) in the 
study group. 
• 171 eyes (86%) presented with visual acuity of 6/36 and 
above. 25 eyes (12%) presented with visual acuity  below 6/36. 
132 eyes (66%) had refractive error, 53 eyes(26%) had early 
lens changes and 12 eyes (6%) had posterior capsular 
opacification. 
• At presentation, 125 eyes (63%) had intraocular pressure in 
low teens and mid teens. 69 eyes (34%) had intraocular 
pressure in high teens. 
• 106 eyes (53%) had normal central corneal thickness(CCT) , 
82 eyes (41%) had higher CCT values and 10 eyes (5%) had 
lower CCT values. 
• 51 patients( 51%) had one of the associated risk factors like 
hypertension, diabetes, hypotension, acute blood loss, 
hemorrhoids, ischemic heart disease, migraine and 
hypercholesterolemia. 
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• 133 eyes (67%) had cup disc ratio distribution between 0.6 and 
0.7. 158 eyes (79%) had nasalization of vessels, 98 eyes (49%) 
had bayoneting of vessels, 146 eyes ( 73%) had laminar dot 
sign, 30 eyes (15%) had baring of circumciliary vessels , 9 
eyes (4%) had splinter hemorrhage and 82 eyes (41%) had 
peripapillary atrophy. 
• 65 eyes( 32%) had field defects involving fixation area and 48 
eyes (24%) had both arcuate scotomas. 
• 112 eyes (56%) had inferior retinal nerve fiber layer(RNFL) 
thinning, 110 eyes(55%) had superior RNFL thinning, 96 
eyes(48%) had nasal RNFL thinning and 92 eyes (46%) had 
temporal RNFL thinning. 
• 53 eyes (26%) had retinal nerve fiber layer thinning in Optical 
Coherence Tomography ,but no field defects in automated 
perimetry. 
• On first followup ( after 3 months), Intraocular pressure 
reduction was achieved in 163 eyes(82%) on treatment with 
topical brimonidine. Fundus changes remained static in all 
eyes. Field defects were static in 124 eyes (62%), regressive in 
66 eyes (33%) and progressive in 8 eyes (4%). Latanoprost 
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was substituted in 4 eyes and Betaxolol was substituted in 4 
eyes. 
• On the subsequent follow up ( after 6 months), Intraocular 
pressure reduction was achieved in 194 eyes( 97%) .Fundus 
changes were progressive in 2 eyes (1%). Field defects were 
progressive in 4 eyes(2%).  2 eyes were started on topical 
latanoprost and in two eyes , trabeculectomy was done with 
post operative intraocular pressure reduction of 30 % and static 
field defects on follow up. 
• On Fundus Flourescein angiographic studies, arm choroidal 
filling time was delayed in 11 out of 15 eyes and arterio-
venous transit time was prolonged in 10 out of 15 eyes. 
•  17 out of 30 eyes had filling defects on the optic nerve head of 
which 13 eyes had corresponding field defects. 
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DISCUSSION 
 Normal tension glaucoma is a diagnostic conundrum1 because a 
diagnosis is made only after diurnal variation of intraocular pressure is 
done and no recording goes above 21 mm of Hg and after correcting the 
intraocular pressure for central corneal thickness. Thus central corneal 
thickness measurement plays an important role in the diagnosis of this 
disease entity. 
 Fundus examination with +90 D biomicroscopy is a must in all 
refraction cases because the disease as such is asymptomatic till the field 
defects progress. So, detecting patients early and beginning treatment 
prevents field defects and blindness due to this disease.  
 Since the disease presents in the elderly especially in the 5th to 6th 
decade, annual or two yearly routine fundus examination leads to early 
detection and hence early treatment.    
 The presence of associated risk factors suggests that the vascular 
pathology either by causing vasospasm or by hypoperfusion  might affect 
the optic nerve head resulting in the progression or the establishment of 
the disease process. 
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 Optical coherence tomography helps in detecting the retinal nerve 
fiber layer thinning even before the occurrence of the field defects. 
Thereby OCT helps in early diagnosis of  normal tension glaucoma.   
 The response to topical  brimonidine is good in these set of patients 
and the other drugs which can also be used are latanoprost and betaxolol. 
Thus, medical control of intraocular pressure ( reduction of IOP by 30%) 
is the main modality of treatment in normal tension glaucoma. The role of 
surgery is minimal in case of normal tension glaucoma, but post surgical 
reduction of intraocular pressure below 30% arrests further progression of 
the defects.     
 Delayed choroidal filling time and prolonged arterio-venous transit 
time indicate that hypoperfusion might be an etiological factor in 
normotensive glaucoma. This opens an eye for further research in the 
field of Normal tension glaucoma, where the etiology is still obscure. In 
addition to it Doppler flowmetry studies might throw a light on the newer 
modalities of management of  Normal tension glaucoma. 
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CONCLUSION 
Central corneal thickness measurement and Diurnal variation test 
play an important role in the diagnosis of Normal tension glaucoma. 
Optical Coherence Tomography aids in the early detection of 
structural damage in the form of retinal nerve fiber layer thinning even 
before it is evident as field defects.   
The progression of field defects in Normal tension glaucoma  is 
arrested by 30% reduction of intraocular pressure, which is achieved by 
medical management with topical brimonidine in 95 % of the eyes.  
The presence of associated risk factors and fundus fluorescein 
angiographic studies indicate that hypoperfusion might be an etiological 
factor in Normal tension glaucoma.   
LIST OF SURGERIES PERFORMED 
S. 
No 
NAME 
AGE / 
SEX 
IP. no. DIAGNOSIS 
DATE OF 
SURGERY 
SURGERY PERFORMED 
1. SAROJA 55/F 416107 LE-MC 25.7.07 LE-ECCE WITH PCIOL
2. RAJI 60/F 418191 BE-IMC 19.9.07 RE-ECCE WITH PCIOL
3. ELUMALAI 60/M 418270 BE-IMC 20.3.08 LE-ECCE WITH PCIOL
4. RAJESHWARI 60/F 426798 BE-IMC 30.5.08 LE-SICS WITH PCIOL
5. RANI 62/F 426021 BE-IMC 6.6.08 RE-SICS WITH PCIOL
6. KUPPU 70/F 422082 BE-IMC 3.3.09 RE-SICS WITH PCIOL
7. SUSEELA 62/F 461141 RE-IMC 14.4.09 RE-SICS WITH PCIOL
8. JOSEPH 60/M 431327 BE-IMC 27.5.08 LE-SICS WITH PCIOL
9. KALAVATHY 45/F 4222021 RE-NVG 19.8.09 RE-TRABECULECTOMY
10 PONNAMMA 50/F 4322451 RE-
CHR.DAC 
18.9.09 RE-DCR  
11 MALATHY 45/F 4344273 LE-
CHR.DAC 
9.10.09 LE-DCR 
12 PUSHPA 43/F 4314523 RE-PTERYG. 17.6.09 RE-PTERYG. EXCISION 
WITH AMNIOTIC 
MEMBRANE GRAFT 
13 MOHAMED 46/M 4423122 LE- PTERYG. 15.7.09 LE-PTERYG.EXCISION
WITH CONJ.AUTOGRAFT 
14 MANJULA 48/F 4432761 RE-PTERYG. 5.8.09 RE-PTERYG.EXCISION 
WITH AMNIOTIC 
MEMBRANE GRAFT 
15 MALLIKA 50/F 432156 RE-IMC 10.8.09 RE-SICS WITH PCIOL 
16 SRINIVASAN 60/M 432257 RE-PSC 24.8.09 RE-SICS WITH PCIOL
17 DHANAPAL 56/M 421343 RE-
ENTROPION 
18.9.09 RE-LATERAL TARSAL 
STRIP PROCEDURE 
18 KUPAYEE 68/F 427833 RE-
CHR.DAC 
25.9.09 RE-
DACRYOCYSTECTOMY 
19 KUMARESAN 65/M 423564 LE-
CORNEAL 
TEAR 
16.10.09 LE- CORNEAL TEAR 
SUTURING DONE 
20 MURUGAVEL 50/M 423534 RE-IMC 14.10.09 RE-SICS WITH PCIOL
S. 
No 
NAME 
AGE / 
SEX 
IP. no. DIAGNOSIS 
DATE OF 
SURGERY 
SURGERY PERFORMED 
21 KANDASAMY 53/M 423345 LE-IMC 21.10.09 LE-SICS WITH PCIOL
22 VELAYAN 50/M 423546 RE-PSC 28.10.09 RE-SICS WITH PCIOL
23 SUBAIYAN 58/M 426754 RE-MC 2.11.09 RE-SICS WITH PCIOL
24 KUPPUSAMY 60/M 426765 LE-PSC 9.11.09 LE-SICS WITH PCIOL
25 MUKILAN 50/M 425656 RE-IMC 25.11.09 RE-SICS WITH PCIOL
 
ABBREVIATIONS 
 
1. RE/LE  - RIGHT EYE / LEFT EYE 
2. IMC  - IMMATURE CATARACT 
3. MC  - MATURE CATARACT 
4. PSC  - POSTERIOR SUBCAPSULAR CATARACT 
5. CHR.DAC - CHRONIC DACRYOCYSTITIS 
6. PTERYG  - PTERYGIUM 
7. ECCE  -  EXTRACAPSULAR CATARACT EXTRACTION 
8. SICS   –  SMALL INCISION CATARACT SURGERY 
9. PCIOL  - POSTERIOR CHAMBER INTRAOCULAR LENS 
10.  DCR  - DACRYOCYSTORHINOSTOMY 
NO NAME AGE SEX EYE V/A CCTCIOP C:D AP RF TRT SUP INF TEM NAS P1 C:D AP TRT P2 C:D AP TRT
HB
% LP
1 PALANI 48 M RE 6/12 PH6/9 578 14 0.7 A/S /I HT B 107 110 54 90 12 0.7 A /S I B 12 0.7 A/ S I B N N
LE 6/12 PH 6/6 602 17 0.8 A / I B 97 120 56 81 14 0.8 A/ I B 12 0.8 A PC B
2 VINAYAK 59 M RE 6/36 PH 6/6 522 15 0.5 R/I - B 121 130 96 110 14 0.5 R/ PC B 14 0.5 R/ PC B N N
LE 6/18 PH 6/6 535 16 0.5 - B 122 132 90 102 14 0.5 - B 14 0.5 - B
3 KRISHNAMOORTHY 48 M RE 6/60 PH 6/6 520 14 0.6 A/S/F  - B 126 139 82 86 12 0.6 R / S /I /F B 12 0.6 R/ F B N N
LE 6/12 PH 6/9 522 14 0.6 A/F B 123 156 67 114 14 0.6 A/F B 12 0.6 A/F B
4 KARPAGAM 55 F RE 6/60 PH 6/18 553 15 0.5 A /S/I MG B 129 146 69 135 12 0.5 R/ S/I B 12 0.5 R/S/I B N N
LE 6/36 PH 6/6 550 14 0.7 R/PC B 130 112 79 106 14 0.7 R/ S/I BL 14 0.7 R/S/I BL
5 RAJENDRAN 58 M RE 6/36 PH 6/9 578 15 0.7 A / S/ I HC B 138 119 55 88 14 0.7 A/ S I B 14 0.7 A/ S I B N ABN
LE 6/24 PH 6/9 580 15 0.7 A/ I B 168 86 68 121 12 0.7 A /I B 14 0.7 A / I B
6 RANGANAYAKI 65 F RE 6/12 PH 6/6 534 12 0.7 A/ PC/F HT B 125 152 63 119 12 0.7 A/ F B 12 0.7 A/ F B N N
LE 6/24 PH 6/6 540 12 0.6 A/ F B 149 111 106 80 12 0.6 A/ F B 12 0.6 A/F B
7 MONISHA 35 F RE 6/36 PH 6/6 580 15 0.4 A / I - B 109 143 120 60 14 0.4 A/ I B 14 0.4 A/I B N N
LE 6/24 PH 6/6 582 15 0.6 A/ I /F B 150 154 79 84 12 0.6 A/F B 14 0.6 A/F B
8 VIJAYAKUMAR 37 M RE 6/24 PH 6/6 522 16 0.7 R/ S - B 112 138 100 83 12 0.7 R/PC B 14 0.7 R/PC B N N
LE 6/9 PH 6/6 529 14 0.8 A/S/I B 88 113 57 90 14 0.8 A/S/I B 14 0.8 A/S/I B
9 NARGEES 44 F RE 6/9 PH 6/6 460 18 0.7 A/S HOT B 82 84 63 90 16 0.7 A/S B 16 0.7 A/S B N N
LE 6/9 ph 6/6 458 16 0.8 A/S/F B 123 156 67 114 16 0.8 A/S/F B 14 0.8 A/S/F B
10 LALITHA 55 F RE 6/12 PH 6/6 583 15 0.5 R/S  - B 133 147 76 111 14 0.5 R/S B 14 0.5 R/S/F L N N
LE 6/24 PH 6/9 587 15 0.7 A/S/F B 81 69 63 54 14 0.7 A/S/F B 14 0.7 A/S B
11 DAYAL 60 M RE 6/12 PH 6/6 530 14 0.7 A/ S HM B 107 120 67 117 12 0.7 A/S B 14 0.7 A/S B DEC N
LE 6/24 PH 6/6 527 14 0.6 A/ S/F B 122 154 75 113 12 0.6 A/S B 14 0.6 A/S B
12 SADAGOPAN 65 M RE 6/12 PH 6/9 535 14 0.6 R/S/I HT B 136 148 80 100 12 0.6 R/S B 12 0.6 R/S B N N
LE 6/12 PH 6/6 530 14 0.7 A/F B 156 152 72 101 14 0.7 A/ F B 12 0.7 A/F B
13 KANNIAMMA 60 F RE 6/36 PH 6/12 540 13 0.5 R/PC - B 136 140 64 102 10 0.5 R/PC B 12 0.5 R/PC B N N
LE 6/24 PH 6/9 538 12 0.6 R/PC/F B 136 143 102 100 12 0.6 R/PC B 12 0.6 R/PC B
14 SHANTHA 50 F RE 6/12 PH  6/6 530 16 0.8 A/S/I - B 121 121 62 88 16 0.8 A/S/I B 14 0.8 A/S/I B N N
LE 6/24 PH 6/6 529 16 0.7 A/S/F B 139 80 81 105 14 0.7 A/S/F B 14 0.7 A/S/F B
15 SUBRAMANI 50 M RE 6/24 PH 6/9 540 14 0.6 R/S IHD B 137 147 100 80 12 0.6 R/PC B 14 0.6 R/PC B N N
LE 6/12 PH 6/6 535 15 0.5 R/S B 145 156 79 93 12 0.5 R/F B 14 0.5 R/F B
16 PALANINATHAN 41 M RE 6/24 PH 6/6 537 14 0.5 R/F - B 163 154 94 115 12 0.5 R/PC B 14 0.5 R/PC B N N
LE 6/12 PH 6/6 536 14 0.6 R/S B 136 142 52 116 12 0.6 R/S B 14 0.6 R/S B
17 RAMAKRISHNAN 65 M RE 6/12 PH6/9 567 15 0.7 A/S /I HOT B 146 158 73 107 12 0.7 A /S I B 12 0.7 A/ S I B N N
LE 6/12 PH 6/6 563 16 0.8 A / I B 125 131 74 83 14 0.8 A/ I B 12 0.8 A/PC B
18 VENKTACHALAM 51 M RE 6/36 PH 6/6/ 522 18 0.5 R/I - B 133 159 97 76 14 0.5 R/ PC B 14 0.5 R/ PC B N N
LE 6/18 PH 6/6 521 20 0.5 R/S B 145 134 90 114 18 0.5 R/S B 18 0.5 - B
19 NOOR MOHAMED 65 M RE 6/60 PH 6/6 520 16 0.6 A/S/F HOT B 134 139 75 98 12 0.6 R / S /I /F B 12 0.6 R/ F B N N
LE 6/12 PH 6/9 522 14 0.6 A/F B 123 148 63 109 14 0.6 A/F B 12 0.6 A/F B
20 NOORISLAM 54 M RE 6/60 PH 6/18 553 15 0.5 A /S/I B 123 138 56 107 12 0.5 R/ S/I B 12 0.5 R/S/I B N N
LE 6/36 PH 6/6/ 550 14 0.7 R/PC B 110 118 69 94 14 0.7 R/ S/I BL 14 0.7 R/S/I BL
21 PARVEEN 29 F RE 6/36 PH 6/9 538 14 0.7 A / S/ I HC B 124 130 74 80 14 0.7 A/ S I B 14 0.7 A/ S I B N ABN
LE 6/24 PH 6/9 534 14 0.7 A/ I B 100 120 76 85 12 0.7 A /I B 14 0.7 A / I B
22 RADHA 48 F RE 6/12 PH 6/6 521 12 0.7 A/ PC/F HT B 121 110 56 80 12 0.7 A/ F B 12 0.7 A/ F B N N
LE 6/24 PH 6/6 514 12 0.6 A/ F B 131 129 88 82 12 0.6 A/ F B 12 0.6 A/F B
23 RAMUTHAI 42 F RE 6/36 PH 6/6 543 15 0.4 A / I - B 161 136 68 90 15 0.4 A/ I B 14 0.4 A/I B N N
LE 6/24 PH 6/6 549 14 0.6 A/ I /F B 134 91 96 116 12 0.6 A/F B 14 0.6 A/F B
24 RAMACHANDRAN 52 M RE 6/24 PH 6/6 487 16 0.7 R/ S - B 103 125 76 100 14 0.7 R/PC B 14 0.7 R/PC B N N
LE 6/9 PH 6/6 483 14 0.8 A/S/I B 98 126 74 75 14 0.8 A/S/I B 14 0.8 A/S/I B
25 LENIN 40 M RE 6/9 PH 6/6 530 19 0.7 A/S HOT B 88 77 76 74 16 0.7 A/S B 16 0.7 A/S B N N
LE 6/9 PH 6/6 532 20 0.8 A/S/F B 122 133 64 91 16 0.8 A/S/F B 14 0.8 A/S/F B
26 LAKSHMI 35 F RE 6/12 PH 6/6 528 16 0.5 R/S  - B 121 144 59 111 14 0.5 R/S B 14 0.5 R/S/F L N N
LE 6/24 PH 6/9 530 14 0.7 A/S/F B 126 139 82 86 12 0.7 A/S/F B 14 0.7 A/S B
27 NAGARAJ 67 M RE 6/12 PH 6/6 532 15 0.7 A/ S  - B 107 102 78 109 12 0.7 A/S B 14 0.7 A/S B N N
LE 6/24 PH 6/6 536 14 0.6 A/ S/F B 109 153 66 125 12 0.6 A/S B 14 0.6 A/S B
28 SAMPATH 70 M RE 6/12 PH 6/9 526 14 0.6 R/S/I HT B 112 87 54 94 12 0.6 R/S B 12 0.6 R/S B N N
LE 6/12 PH 6/6 530 14 0.7 A/F B 161 181 90 90 14 0.7 A/ F B 12 0.7 A/F B
29 PUSHPARAJ 47 M RE 6/36 PH 6/12 538 13 0.5 R/PC - B 142 116 46 117 12 0.5 R/PC B 12 0.5 R/PC B N N
LE 6/24 PH 6/9 538 12 0.6 R/PC/F B 143 137 62 107 12 0.6 R/PC B 12 0.6 R/PC B
30 PHILOMINA 68 F RE 6/12 PH  6/6 530 16 0.8 A/S/I - B 97 111 56 97 16 0.8 A/S/I B 14 0.8 A/S/I B N N
LE 6/24 PH 6/6 536 16 0.7 A/S/F B 100 99 56 85 14 0.7 A/S/F B 14 0.7 A/S/F B
31 PADMANABAN 65 M RE 6/24 PH 6/9 540 14 0.6 R/S HM B 135 134 72 125 12 0.6 R/PC B 14 0.6 R/S L N N
LE 6/12 PH 6/6 535 14 0.5 R/S B 150 118 53 106 12 0.5 R/F B 14 0.5 R/F B
32 THANGARAJ 61 M RE 6/60 PH 6/24 532 16 0.6 A/I - B 130 148 69 105 16 0.6 A/I B 14 0.6 A/I B N N
LE 6/60 PH 6/24 540 16 0.8 A/S/I B 100 123 56 83 14 0.8 A/S/I B 14 0.8 A/S/I B
33 KUMARI 55 F RE 6/36 PH 6/9 582 15 0.6 R/S - B 146 145 65 114 14 0.6 R/S/I BL 14 0.6 R/S BL N N
LE 6/12 PH 6/6 589 15 0.5 R/I B 140 127 76 119 14 0.5 R/I B 14 0.5 R/I B
34 ASHOK 50 M RE 6/24 PH 6/9 583 17 0.5 R/S/I PVD B 136 133 67 101 14 0.5 R/S B 14 0.5 R/S B N N
LE 6/12 PH 6/6 580 15 0.6 R/S/F B 144 117 82 76 14 0.6 R/S B 14 0.6 R/S B
35 BABY 67 F RE 6/60 PH 6/36 542 14 0.6 A/F - B 148 157 61 122 12 0.6 A/F/PC BL 14 0.6 A/PC BL N N
LE 6/36 PH 6/24 536 14 0.7 A/S/I B 159 160 52 95 12 0.7 A/S/I B 14 0.7 A/S/I B
36 LILLY PUSHPAM 64 F RE 6/60 PH 6/36 530 16 0.7 A/I DM B 136 133 67 101 14 0.7 A/I B 14 0.7 A/I B N N
LE 6/36 PH 6/24 528 16 0.6 R/ S/I B 147 141 55 120 14 0.6 R/S B 14 0.7 R/S B
37 JOTHY 63 F RE 6/9 PH 6/6 532 16 0.8 A/S/F B 121 110 60 76 16 0.8 A/S/F B 14 0.8 A/S/F B N N
LE 6/12 PH 6/6 536 14 0.5 R/S  - B 171 178 86 139 14 0.5 R/S B 14 0.5 R/S B
38 RAGHUNATHAN 45 M RE 6/24 PH 6/9 530 14 0.7 A/S/F MG B 121 132 64 98 12 0.7 A/S/F B 14 0.7 A/S B N N
LE 6/12 PH 6/6 527 14 0.7 A/ S  - B 128 117 66 86 12 0.7 A/S B 14 0.7 A/S B
39 ESWARAN 60 M RE 6/24 PH 6/6 536 14 0.6 A/ S/F B 132 109 63 103 11 0.6 A/S B 14 0.6 A/S B N N
LE 6/12 PH 6/9 535 14 0.6 R/S/I HT B 109 99 65 76 12 0.6 R/S B 12 0.6 R/S B
40 SRINIVASAN 59 M RE 6/12 PH 6/6 585 15 0.7 A/F B 129 116 60 85 14 0.7 A/ F B 12 0.7 A/F B N N
LE 6/36 PH 6/12 589 13 0.5 R/PC - B 135 132 65 104 12 0.5 R/PC B 12 0.5 R/PC B
41 ROBERT 70 M RE 6/24 PH 6/9 538 12 0.6 R/PC/F B 137 132 82 76 12 0.6 R/PC B 12 0.6 R/PC B N N
LE 6/12 PH  6/6 530 16 0.8 A/S/I - B 108 121 65 54 16 0.8 A/S/I B 14 0.8 A/S/I B
42 PITCHAIAMMAL 60 F RE 6/24 PH 6/6 536 16 0.7 A/S/F IHD B 133 142 79 106 14 0.7 A/S/F B 14 0.7 A/S/F B N N
LE NO PL  -  - - - - -  -  -  -  - - - - - - - - -
43 ESWARAPILLAI 57 M RE 6/60 PH 6/36 540 14 0.6 A/S/I DM B 129 146 69 135 11 0.6 A/S/I B 14 0.6 A/S/I B N N
LE 6/36 PH 6/18 542 14 0.7 A/S/I B 119 132 65 98 11 0.7 A/S/I B 14 0.7 A/S/I B
44 RAMAN 55 M RE NO PL  -  -  - - DM B  -  -  -  -               -  -  -  - -  - N N
LE 6/12 PH 6/9 537 14 0.6 A/S B 126 140 66 132 14 0.6 A/S B 14 0.6 A/S B
45 KASINATHAN 65 M RE 6/18 PH 6/12 525 16 0.6 A/I DM B 133 136 78 104 16 0.6 A/I B 14 0.6 A/I B N N
LE 6/60 NIP 528 16 0.7 A/S/I B 125 122 74 98 16 0.7 A/I B 14 0.7 A/I B
46 MARGABANDHU 51 M RE 6/18 PH 6/12 492 14 0.5 R/PC HT B 130 114 74 128 14 0.5 R/PC B 14 0.5 R/PC B N N
LE 6/18 PH 6/6 497 14 0.7 R/S/I B 110 98 65 99 14 0.7 R/S/I B 14 0.7 R/S/I B
47 PREMA 52 F RE 5/60 PH 6/36 520 16 0.6 R/S/I  - B 126 139 82 86 14 0.6 R/S B 14 0.6 R/S B N N
LE 6/60 PH 6/12 526 16 0.6 R/S B 123 156 67 96 14 0.6 R/S B 14 0.6 R /PC B
48 JAGATHA 60 F RE 6/18 PH 6/12 540 16 0.4 R/PC HT B 147 135 68 102 14 0.6 A/S L 14 0.6 A/S L N N
LE 6/12 PH 6/6 546 16 0.6 R/S/I B 134 124 76 98 14 0.6 R/S B 14 0.6 R/S B
49 PATCHAIAMMAL 44 F RE 6/36 PH 6/18 530 18 0.6 R/S/I HC B 126 112 75 100 16 0.6 R/S B 16 0.6 R/S B N N
LE 6/36 PH 6/6 532 18 0.7 R/S/I B 123 110 78 94 16 0.7 R/S/I B 16 0.7 R/S B
50 HABINISA 65 F RE 6/60 PH 6/24 546 16 0.5 R/I DM/HT B 135 146 104 86 14 0.5 R/I B 14 0.5 R/I B N N
LE 6/12 PH 6/6 535 16 0.7 R/PC B 125 130 74 86 16 0.7 R/PC B 14 0.7 R/PC B
51 THILAGAN 65 M RE 6/12 PH 6/9 522 14 0.6 A/F  - B 129 145 68 130 12 0.6 A/F B 12 0.6 A/F B N N
LE 6/60 PH 6/18 520 14 0.5 A /S/I B 130 114 57 125 12 0.5 R/ S/I B 12 0.5 R/S/I B
52 KAVITHA 45 F RE 6/36 PH 6/6 532 14 0.7 A/S  - B 122 98 66 54 14 0.7 A/S/I L 14 0.8 A/S/I/FTRAB N N
LE 6/36 PH 6/9 538 14 0.7 A/S/I B 110 107 86 99 14 0.7 A/ S I B 14 0.7 A/ S I B
53 BALASUBRAMANIAM 65 M RE 6/24 PH 6/9 460 15 0.7 A/ I HT B 124 108 75 87 14 0.7 A /I B 14 0.7 A / I B N ABN
LE 6/12 PH 6/6 471 13 0.7 A/ PC/F B 120 106 78 90 12 0.7 A/ F B 12 0.7 A/ F B
54 SAMPATH 51 M RE 6/24 PH 6/6 540 12 0.6 A/ F  - B 130 120 78 99 12 0.6 A/ F B 12 0.6 A/F B N N
LE 6/36 PH 6/6 543 14 0.4 A / I B 140 147 74 125 14 0.4 A/ I B 14 0.4 A/I B
55 MADHAVAN 55 M RE 6/24 PH 6/6 540 16 0.6 A/ I /F  - B 125 112 78 102 14 0.6 A/F B 14 0.6 A/F B N N
LE 6/24 PH 6/6 542 16 0.7 R/ S B 124 116 76 90 14 0.7 R/PC B 14 0.7 R/PC B
56 MAHADEVAN 53 M RE 6/9 PH 6/6 539 14 0.8 A/S/I HM B 118 108 68 67 14 0.8 A/S/I B 14 0.8 A/S/I B DEC N
LE 6/9 PH 6/6 530 18 0.7 A/S B 121 110 72 75 16 0.7 A/S B 16 0.7 A/S B
57 RUDRAVENI 45 F RE 6/12 NIP 528 16 0.8 A/S/F  - B 135 107 78 65 16 0.8 A/S/F B 14 0.8 A/S/F B N N
LE 6/12 PH 6/6 521 14 0.5 R/S B 133 134 76 121 14 0.5 R/S B 14 0.5 R/S B
58 HAMSAKUMARI 50 F RE 6/24 PH 6/9 530 14 0.7 A/S/F HT B 122 110 78 95 12 0.7 A/S/F B 14 0.7 A/S B N N
LE 6/12 PH 6/6 540 14 0.7 A/ S B 126 128 82 89 12 0.7 A/S B 14 0.7 A/S B
59 VEDHANAYAGAM 55 M RE 6/24 PH 6/6 486 14 0.6 A/ S/F HT B 136 130 98 102 14 0.6 A/S B 14 0.6 A/S B N N
LE 6/12 PH 6/9 483 14 0.6 R/S/I B 143 134 95 100 12 0.6 R/S B 12 0.6 R/S B
60 VELU 60 M RE 6/12 PH 6/6 530 14 0.7 A/F DM B 126 100 56 91 14 0.7 A/ F B 12 0.7 A/F B N N
LE 6/36 PH 6/12 540 12 0.5 R/PC B 123 101 83 96 12 0.5 R/PC B 12 0.5 R/PC B
61 KAANTHA 55 F RE 6/24 PH 6/9 538 12 0.6 R/PC/F  - B 124 155 65 114 12 0.6 R/PC B 12 0.6 R/PC B N N
LE 6/12 PH  6/6 530 16 0.8 A/S/I B 120 110 55 98 16 0.8 A/S/I B 14 0.8 A/S/I B
62 PUSHPALATHA 55 F RE 6/24 PH 6/6 534 16 0.7 A/S/F DM B 126 112 66 90 14 0.7 A/S/F B 14 0.7 A/S/F B N N
LE 6/24 PH 6/9 540 14 0.6 R/S B 122 108 82 93 14 0.6 R/PC B 14 0.6 R/PC B
63 KUPPAMAL 40 F RE 6/12 PH 6/6 535 14 0.5 R/S  - B 135 120 79 77 14 0.5 R/F B 14 0.5 R/F B N N
LE 6/24 PH 6/6 537 14 0.5 R/F B 136 130 65 110 14 0.5 R/PC B 14 0.5 R/PC B
64 KARTHIKEYAN 55 M RE 6/18 PH 6/6 547 16 0.6 A/I - B 124 155 67 115 14 0.6 A/I B 14 0.6 A/I B N N
LE 6/18 PH 6/9 542 14 0.4 R/S B 153 139 71 108 14 0.4 R/S B 14 0.4 R/S B
65 SWARNALATHA 70 F RE 6/36 PH 6/9 530 16 0.5 R/PC - B 133 130 78 120 14 0.5 R/PC B 14 0.5 R/PC B N N
LE 6/24 PH 6/9 527 16 0.6 R/S/I B 140 156 77 127 14 0.6 R/S/I B 14 0.6 R/S B
66 ELUMALAI 60 M RE 6/36 PH 6/6 581 15 0.7 A/S/I - B 141 138 84 101 12 0.7 A/S/I B 14 0.7 A/S/I B N N
LE 6/60 PH 6/9 583 15 0.7 A/I B 161 154 91 96 12 0.7 A/I B 14 0.7 A/I B
67 SAMPATH 65 M RE 6/60 PH 6/24 530 16 0.6 A/PC/F DM B 134 107 77 88 14 0.6 A/PC/F B 14 0.6 A/PC/F B N N
LE 6/24 PH 6/12 522 16 0.7 A/S B 103 92 78 89 14 0.7 A/S B 14 0.7 A/S B
68 VARADHARAJAN 55 M RE 6/12 PH 6/6 512 14 0.5 R/S/I HOT B 131 122 69 106 12 0.5 R/S B 12 0.5 R/S B N N
LE 6/18 PH 6/9 517 14 0.7 A/S/I B 93 102 79 97 14 0.7 A/S/I B 14 0.7 A/S/I B
69 KANNAN 48 M RE 6/12 PH 6/6 539 14 0.7 A/S/I  - B 116 106 86 98 12 0.7 A/S B 14 0.7 A/S B N N
LE 6/12 PH 6/6 536 14 0.5 R/S/F B 138 154 100 102 12 0.5 R/S/F B 14 0.5 R/S B
70 RAVIKUMAR 43 M RE 6/24 PH 6/6 540 14 0.6 R/S/I ABL B 134 107 88 77 14 0.6 R/S B 14 0.6 R/S B N N
LE 6/12 PH 6/6 543 14 0.5 R/S B 107 153 84 112 14 0.5 R/S B 14 0.5 R/S B
71 VANITHA 35 F RE 6/36 PH 6/9 562 16 0.7 A/S/F - B 122 135 86 102 14 0.7 A/S/F B 14 0.7 R/S B N N
LE 6/24 PH 6/9 559 14 0.6 A/F B 124 132 96 94 14 0.6 A/F B 14 0.6 A/F B
72 PARAMESWARAN 50 M RE 6/9 PH 6/6 527 14 0.5 R/S IHD B 119 126 78 91 14 0.5 R/PC B 14 0.5 R/PC B N N
LE 6/9 PH 6/6 523 14 0.6 R/S/I B 121 130 49 105 14 0.6 R/S/I B 14 0.6 R/S/I B
73 SASIKALA 45 F RE 6/24 PH 6/6 540 16 0.7 A/S/I - B 125 152 63 119 16 0.7 A/S/I B 14 0.7 A/S/I B N N
LE 6/18 PH 6/6 545 16 0.6 A/S/F B 150 154 84 79 14 0.6 A/S/F B 14 0.6 A/S/F B
74 MEENAKSHI 67 F RE 6/60 PH 6/9 522 16 0.6 A/F - B 109 143 100 120 16 0.6 A/F B 16 0.6 A/F B N N
LE 6/36 PHH 6/6 526 14 0.5 R/PC B 156 151 87 96 16 0.5 R/PC B 14 0.5 R/PC B
75 SUBASH 60 M RE 6/18 PH 6/12 540 16 0.6 A/I DM B 149 111 80 106 16 0.6 A/I B 14 0.6 A/I B N N
LE 6/60 NIP 543 16 0.7 A/S/I B 108 86 68 129 16 0.7 A/I B 14 0.7 A/I B
76 SARASWATHI 52 F RE 6/18 PH 6/12 536 14 0.5 R/PC  - B 130 142 93 119 14 0.5 R/PC B 14 0.5 R/PC B N N
LE 6/18 PH 6/6 538 14 0.7 R/S/I B 110 126 88 100 14 0.7 R/S/I B 14 0.7 R/S/I B
77 ARUMUGAM 45 M RE 5/60 PH 6/36 542 16 0.6 R/S/I  - B 112 102 90 95 14 0.6 R/S B 14 0.6 R/S B N N
LE 6/60 PH 6/12 547 16 0.6 R/S B 102 94 88 96 14 0.6 R/S B 14 0.6 R /PC B
78 VENUGOPAL 62 M RE 6/18 PH 6/12 540 16 0.4 R/PC - B 105 140 75 109 14 0.4 R/PC B 14 0.4 - B N N
LE 6/12 PH 6/6 546 16 0.6 R/S/I B 120 118 68 95 14 0.6 R/S B 14 0.6 R/S B
79 MANOHARAN 50 M RE 6/36 PH 6/18 490 18 0.6 R/S/I DM B 119 104 72 97 16 0.6 R/S B 16 0.6 R/S B N N
LE 6/36 PH 6/6 489 18 0.7 R/S/I B 108 102 68 90 16 0.7 R/S/I B 16 0.7 R/S B
80 RAMASAMY 65 M RE 6/60 PH 6/24 546 16 0.5 R/I - B 103 130 75 100 14 0.5 R/I B 14 0.5 R/I B N N
LE 6/12 PH 6/6 535 16 0.7 A/S B 141 113 90 67 16 0.7 A/S B 14 0.7 A/S B
81 JAYA 60 F RE 6/12 PH 6/9 522 15 0.6 A/F  - B 109 126 88 94 12 0.6 A/F B 12 0.6 A/F B N N
LE 6/60 PH 6/18 553 14 0.5 A /S/I B 125 118 93 95 12 0.5 R/ S/I B 12 0.5 R/S/I B
82 SUNDARAMURTHY 55 M RE 6/36 PH 6/6/ 528 14 0.7 R/PC HC B 124 132 62 96 14 0.7 R/ S/I L 14 0.7 R/S/I L N ABN
LE 6/36 PH 6/9 530 14 0.7 A / S I B 122 102 74 86 14 0.7 A/ S I B 14 0.7 A/ S I B
83 KARNAN 48 M RE 6/24 PH 6/6 535 14 0.7 A/S/I - B 126 100 75 96 14 0.7 A/S/I B 14 0.7 A/S/I B N N
LE 6/36 PH 6/9 545 15 0.6 A/F B 102 130 72 105 12 0.6 A/F B 14 0.6 A/F B
84 SAMPATH KUMAR 70 M RE 6/24 PH 6/18 550 16 0.7 R/S/I IHD B 135 114 63 102 14 0.7 R/S/I B 14 0.7 R/S B N N
LE 6/18 PH 6/6 548 16 0.5 R/S B 114 131 99 73 14 0.5 R/S B 14 0.5 R/S B
85 KONDIAMAL 53 M RE 6/12 PH 6/6 550 14 0.6 A/S - B 128 96 93 72 14 0.6 A/S B 14 0.6 R/S B N N
LE 6/18 PH 6/6 552 14 0.7 A /S /I B 135 114 62 104 12 0.7 A/S/I B 14 0.7 A/S/I B
86 BAKIAVATHY 55 M RE 6/24 PH 6/6 529 14 0.7 R/PC HC B 124 154 71 105 14 0.7 A/S L 14 0.7 R/S/I L N ABN
LE 6/24 PH 6/6 520 15 0.7 A/S/I B 129 120 62 105 12 0.7 A/ S I B 14 0.7 A/ S I B
87 RAMALINGAM 65 M RE 6/9 PH 6/6 530 14 0.7 A/ I HT B 133 104 59 102 14 0.7 A /I B 14 0.7 A / I B N N
LE 6/9 PH 6/6 527 12 0.7 A/ PC/F B 110 96 60 100 12 0.7 A/ F B 12 0.7 A/ F B
88 DEVARAJ 50 M RE 6/12 NIP 540 12 0.6 A/ F  - B 142 142 89 100 12 0.6 A/ F B 12 0.6 A/F B N N
LE 6/12 PH 6/6 543 14 0.4 A / I B 139 143 78 89 12 0.4 A/ I B 14 0.4 A/I B
89 MOHANKUMAR 54 M RE 6/24 PH 6/9 530 16 0.6 A/ I /F  - B 155 142 75 130 14 0.6 A/F B 14 0.6 A/F B N N
LE 6/12 PH 6/6 528 16 0.7 R/ S B 126 130 70 95 14 0.7 R/PC B 14 0.7 R/PC B
90 MARAGATHAM 58 F RE 6/60 NIP 529 14 0.8 A/S/I HM B 124 126 74 90 12 0.8 A/S/I B 14 0.8 A/S/I B DEC N
LE 6/12 PH 6/9 530 18 0.7 A/S B 136 130 80 94 16 0.7 A/S B 16 0.7 A/S B
91 PUSHPARAJ 60 M RE 6/12 PH 6/6 532 16 0.8 A/S/F  - B 132 125 75 90 16 0.8 A/S/I L 16 0.8 A/S/I/FTRAB N N
LE 6/60 NIP 536 14 0.5 R/S B 110 112 86 76 14 0.5 R/S B 14 0.5 R/S/F B
92 JANAKI 58 F RE 6/24 PH 6/9 521 15 0.7 A/S/F HT B 121 123 68 98 14 0.7 A/S/F B 14 0.7 A/S B N N
LE 6/36 NIP 530 14 0.7 A/ S B 122 120 74 91 14 0.7 A/S B 14 0.7 A/S B
93 RAJALAKSHMI 55 F RE 6/24 PH 6/6 536 14 0.6 A/ S/F HT B 100 128 82 105 14 0.6 A/S B 14 0.6 A/S B N N
LE 6/24 PH 6/9 535 14 0.6 R/S/I B 125 120 65 104 12 0.6 R/S B 12 0.6 R/S B
94 JACQUILINE 45 F RE 6/12 PH 6/6 530 15 0.7 A/F DM B 126 127 71 77 14 0.7 A/ F B 12 0.7 A/F B N N
LE 6/24 PH 6/6 540 12 0.5 R/PC B 117 116 54 76 12 0.5 R/PC B 12 0.5 R/PC B
95 RAMESHKUMAR 53 M RE 6/18 PH 6/6 528 12 0.6 R/PC/F  - B 127 95 93 73 12 0.6 R/PC B 12 0.6 R/PC B N N
LE 6/24 PH 6/9 530 16 0.8 A/S/I B 122 104 62 70 16 0.8 A/S/I B 14 0.8 A/S/I B
96 HEMALATHA 35 F RE 6/36 PH 6/12 534 16 0.7 A/S/F DM B 135 114 62 102 14 0.7 A/S/F B 14 0.7 A/S/F B N N
LE 6/24 PH 6/9 540 14 0.6 R/S B 128 96 93 72 14 0.6 R/PC B 14 0.6 R/PC B
97 SUBRAMANI 50 M RE 6/24 NIP 535 14 0.5 R/S HT B 128 120 44 84 12 0.5 R/F B 14 0.5 R/F B N N
LE 6/24 PH 6/9 540 12 0.5 R/PC - B 138 119 55 88 12 0.5 R/PC B 12 0.5 R/PC B N N
98 GEETHALAKSHMI 58 M RE 6/60 PH 6/12 490 12 0.6 R/PC/F B 110 140 56 109 12 0.6 R/PC B 12 0.6 R/PC B
LE 6/24 PH 6/6 495 16 0.8 A/S/I - B 125 150 63 47 16 0.8 A/S/I B 14 0.8 A/S/I B N N
99 KUMARAN 60 M RE 6/60 PH 6/36 534 16 0.7 A/S/F ABL B 150 154 84 79 14 0.7 A/S/F B 14 0.7 A/S/F B
LE 6/60 PH 6/18 540 14 0.6 R/S - B 131 171 78 100 14 0.6 R/PC B 14 0.6 R/PC B N N
100 SEETHA 62 F RE 6/36 PH 6/12 520 14 0.5 R/S B 125 118 96 93 14 0.5 R/F B 14 0.5 R/F B
LE 6/24 PH 6/6 527 14 0.5 R/F - B 102 130 72 105 14 0.5 R/PC B 14 0.5 R/PC B N N
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KEY  TO  MASTER CHART 
 
NO   - SERIAL NUMBER 
V/A  - VISUAL ACUITY 
PH   - PIN HOLE 
CCT  - CENTRAL CORNEAL THICKNESS 
CIOP  - CCT CORRECTED INTRAOCULAR PRESSURE 
C:D  - CUP: DISC RATIO 
AP  - FIELDS BY AUTOMATED PERIMETRY 
A  - ABSOLUTE DEFECTS 
R  - RELATIVE DEFECTS 
S  - SUPERIOR ARCUATE AREA 
I  - INFERIOR ARCUATE AREA 
F  - FIXATION AREA 
PC  - PARACENTRAL AREA 
RF  - RISK FACTORS 
HT  - HYPERTENSION 
HOT  - HYPOTENSION 
DM  - DIABETES MELLITUS 
IHD  - ISCHEMIC HEART DISEASE 
HC  - HYPERCHOLESTEROLEMIA 
HM  - HEMORRHOIDS 
ABL  - ACUTE BLOOD LOSS 
MG  - MIGRAINE 
PVD  - PERIPHERAL VASCULAR DISEASE 
TRT  - TREATMENT 
RNFL - RETINAL NERVE FIBER LAYER THICKNESS 
SUP  - SUPERIOR 
INF  - INFERIOR 
TEM  - TEMPORAL 
NAS  - NASAL 
B  - BRIMONIDINE EYE DROPS TWICE DAILY 
L - LATANOPROST EYE DROPS ONCE DAILY AT 
 BED TIME 
BL - BETAXOLOL EYE DROPS TWICE DAILY 
TRA - TRABECULECTOMY  
P1 - IOP ON FOLLOW UP 1 
P2 - IOP ON FOLLOW UP 2 
HB % - HEMOGLOBIN  
LP - LIPID PROFILE 
N - NORMAL 
ABN - ABNORMAL 
DEC -  DECREASED 
  
PROFORMA FOR THE CLINICAL ANALYSIS OF 
NORMAL TENSION GLAUCOMA 
 
NAME:                                                      ADDRESS:                                                 
AGE:                SEX:                                       
G.C.No:                                                       PHONE NO: 
HISTORY: 
‐ DEFECTIVE VISION :RE/LE/BE    DURATION: 
‐ HEADACHE 
‐ FREQUENT CHANGE OF SPECTACLES 
‐ TRAUMA 
‐ RECURRENT ATTACKS OF REDNESS / PAIN/ WATERING 
‐ H/O STEROID INTAKE 
RISK FACTORS: 
 
TICK 
IF 
YES 
DURATION TREATMENT 
DIABETES    
HYPERTENSION    
HYPOTENSION    
ISCHEMIC HEART DISEASE    
HEADACHE/ MIGRAINE    
HYPERCHOLESTEROLEMIA    
HEMORRHOIDS    
PERIPHERAL VASCULAR 
DISEASE 
   
ACUTE BLOOD LOSS- RTA    
IMMUNOLOGICAL 
DISORDER 
   
 
PAST HISTORY : 
PREVIOUS HISTORY OF INTRAOCULAR SURGERY 
OCULAR EXAMINATION: 
 RE LE 
V/A(BCVA)   
IOP    
CCT   
CCT CORRECTED IOP   
ANTERIOR SEGMENT   
FUNDUS: MEDIA: 
                 C:D RATIO: 
                 PALLOR: 
               NASALISATION: 
              BAYONETTING: 
    LAMINAR DOT SIGN: 
SPLINTER HEMORRHAGE: 
 PERIPAPILLARY  
ATROPHY:        
  
GONIOSCOPY:  
 
 
 
AUTOMATED 
PERIMETRY: 
              RELIABILITY: 
                DEFECTS: 
                REGION: 
           FIXATION AREA: 
  
DIURNAL IOP MONITORING: 
 
TIME RE LE 
   
   
   
   
   
   
 
TREATMENT:-- 
OCT: 
RNFL THICKNESS   
           SUPERIOR:   
          INFERIOR:   
          TEMPORAL:   
             NASAL:   
 
LAB INVESTIGATIONS: 
1. HEMOGLOBIN: 
2. LIPID PROFILE: 
 
FFA:    ARM-CHOROIDAL FILLING TIME: 
            ARTERIO-VENOUS TRANSIT PHASE: 
           FILLING DEFECTS ON THE ONH:     
 
FOLLOW UP:  
1. DATE: 
2. DRUGS: 
3. COMPLIANCE: 
4. V/A: 
5. IOP: 
6. ANTERIOR SEGMENT: 
7. FUNDUS: 
8.  AUTOMATED PERIMETRY:               
9. STATIC/PROGRESSION/REGRESSION: 
10. ADVICE: 
  
LIST OF SURGERIES PERFORMED 
S. 
No 
NAME AGE / SEX IP. no. 
DIAGN
OSIS 
DATE 
OF 
SURGER
Y 
SURGERY 
PERFORMED 
1. SAROJA 55/F 416107 LE-MC 25.7.07 LE-ECCE WITH 
PCIOL 
2. RAJI 60/F 418191 BE-IMC 19.9.07 RE-ECCE WITH 
PCIOL 
3. ELUMAL
AI 
60/M 418270 BE-IMC 20.3.08 LE-ECCE WITH 
PCIOL 
4. RAJESHW
ARI 
60/F 426798 BE-IMC 30.5.08 LE-SICS WITH 
PCIOL 
5. RANI 62/F 426021 BE-IMC 6.6.08 RE-SICS WITH 
PCIOL 
6. KUPPU 70/F 422082 BE-IMC 3.3.09 RE-SICS WITH 
PCIOL 
7. SUSEELA 62/F 461141 RE-IMC 14.4.09 RE-SICS WITH 
PCIOL 
8. JOSEPH 60/M 431327 BE-IMC 27.5.08 LE-SICS WITH 
PCIOL 
9. KALAVAT
HY 
45/F 422202
1 
RE-NVG 19.8.09 RE-
TRABECULECT
OMY 
10 PONNAM
MA 
50/F 432245
1 
RE-
CHR.DA
C 
18.9.09 RE-DCR  
11 MALATH
Y 
45/F 434427
3 
LE-
CHR.DA
C 
9.10.09 LE-DCR 
12 PUSHPA 43/F 431452
3 
RE-
PTERY
G. 
17.6.09 RE-PTERYG. 
EXCISION WITH 
AMNIOTIC 
MEMBRANE 
S. 
No 
NAME AGE / SEX IP. no. 
DIAGN
OSIS 
DATE 
OF 
SURGER
Y 
SURGERY 
PERFORMED 
GRAFT 
13 MOHAME
D 
46/M 442312
2 
LE- 
PTERY
G. 
15.7.09 LE-
PTERYG.EXCISI
ON 
WITH 
CONJ.AUTOGRA
FT 
14 MANJULA 48/F 443276
1 
RE-
PTERY
G. 
5.8.09 RE-
PTERYG.EXCISI
ON WITH 
AMNIOTIC 
MEMBRANE 
GRAFT 
15 MALLIKA 50/F 432156 RE-IMC 10.8.09 RE-SICS WITH 
PCIOL  
16 SRINIVAS
AN 
60/M 432257 RE-PSC 24.8.09 RE-SICS WITH 
PCIOL 
17 DHANAPA
L 
56/M 421343 RE-
ENTRO
PION 
18.9.09 RE-LATERAL 
TARSAL STRIP 
PROCEDURE 
18 KUPAYEE 68/F 427833 RE-
CHR.DA
C 
25.9.09 RE-
DACRYOCYSTE
CTOMY 
19 KUMARE
SAN 
65/M 423564 LE-
CORNE
AL 
TEAR 
16.10.09 LE- CORNEAL 
TEAR 
SUTURING 
DONE 
20 MURUGA
VEL 
50/M 423534 RE-IMC 14.10.09 RE-SICS WITH 
PCIOL 
21 KANDASA 53/M 423345 LE-IMC 21.10.09 LE-SICS WITH 
S. 
No 
NAME AGE / SEX IP. no. 
DIAGN
OSIS 
DATE 
OF 
SURGER
Y 
SURGERY 
PERFORMED 
MY PCIOL 
22 VELAYAN 50/M 423546 RE-PSC 28.10.09 RE-SICS WITH 
PCIOL 
23 SUBAIYA
N 
58/M 426754 RE-MC 2.11.09 RE-SICS WITH 
PCIOL 
24 KUPPUSA
MY 
60/M 426765 LE-PSC 9.11.09 LE-SICS WITH 
PCIOL 
25 MUKILAN 50/M 425656 RE-IMC 25.11.09 RE-SICS WITH 
PCIOL 
 
ABBREVIATIONS 
 
1. RE/LE  - RIGHT EYE / LEFT EYE 
2. IMC  - IMMATURE CATARACT 
3. MC  - MATURE CATARACT 
4. PSC  - POSTERIOR SUBCAPSULAR 
CATARACT 
5. CHR.DAC - CHRONIC DACRYOCYSTITIS 
6. PTERYG  - PTERYGIUM 
7. ECCE  -  EXTRACAPSULAR CATARACT 
EXTRACTION 
8. SICS   –  SMALL INCISION CATARACT 
SURGERY 
9. PCIOL  - POSTERIOR CHAMBER 
INTRAOCULAR LENS 
10. DCR  - DACRYOCYSTORHINOSTOMY 
 
